BA-3182

N/A

Report date: 2026/03/19 17:01:27

Base Information

Drug NameBA-3182

Drug Alias NameBA-3182

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-EpCAMAnti-CD3

TargetsEpithelial cell adhesion moleculeT cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumoursAdenocarcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBioAtla Inc

China Registration ClassN/A

Develop Information

Active CompaniesBioAtla Inc

Inactive CompaniesN/A

Active IndicationsAdenocarcinoma

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A